Literature DB >> 8738427

Cytokine regulation of HIV replication induced by dendritic cell-CD4-positive T cell interactions.

D Weissman1, J Daucher, T Barker, J Adelsberger, M Baseler, A S Fauci.   

Abstract

It has been established that human immunodeficiency virus (HIV) replication occurs throughout the course of disease in the lymphoid tissue. We have developed a model system to study the effect of cytokines and other agents on HIV replication using cocultures of DCs and T cells that reflect the cell-to-cell interactions that occur in the microenvironment of lymphoid tissue. Dendritic cells from peripheral blood, when pulsed with small amounts of HIV, induce infection in autologous, unstimulated CD4-positive T cells. Using this system, cytokines, anti-cytokine antibodies, and inhibitors of cellular activation were added to cultures and the effects on cellular proliferation and activation and HIV production were measured. Cytokines that increased T cell proliferation, such as IL-2 and IL-4, enhanced HIV replication, while the effect of IL-12 was more complex. HIV production was inhibited by blocking endogenously produced IL-2, as well as by adding IL-10, which blocks IL-2 secretion, antigen-presenting cell function, and T cell activation. Proinflammatory cytokines induced modest enhancement of viral replication in cocultures of HIV-pulsed DCs and CD4-positive T cells. Thus, using a model of HIV replication that more closely mimics the in vivo microenvironment of lymphoid tissue may allow a better analysis of the effect of cytokines and cytokine networks, as well as agents that modify immune activation on HIV replication.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8738427     DOI: 10.1089/aid.1996.12.759

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  9 in total

1.  Latent HIV-1 can be reactivated by cellular superinfection in a Tat-dependent manner, which can lead to the emergence of multidrug-resistant recombinant viruses.

Authors:  Daniel A Donahue; Sophie M Bastarache; Richard D Sloan; Mark A Wainberg
Journal:  J Virol       Date:  2013-06-26       Impact factor: 5.103

2.  Variants from the diverse virus population identified at seroconversion of a clade A human immunodeficiency virus type 1-infected woman have distinct biological properties.

Authors:  M Poss; J Overbaugh
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

3.  Role of dendritic cells in the immune response induced by mouse mammary tumor virus superantigen.

Authors:  F Baribaud; I Maillard; S Vacheron; T Brocker; H Diggelmann; H Acha-Orbea
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

4.  Macaques with rapid disease progression and simian immunodeficiency virus encephalitis have a unique cytokine profile in peripheral lymphoid tissues.

Authors:  M S Orandle; K C Williams; A G MacLean; S V Westmoreland; A A Lackner
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

5.  SIVsm Tat, Rev, and Nef1: functional characteristics of r-GV internalization on isotypes, cytokines, and intracellular degradation.

Authors:  Marinko Sremac; Elizabeth S Stuart
Journal:  BMC Biotechnol       Date:  2010-07-19       Impact factor: 2.563

6.  Multiparameter analysis of clastogenic factors, pro-oxidant cytokines, and inflammatory markers in HIV-1-infected patients with asymptomatic disease, opportunistic infections, and malignancies.

Authors:  J Fuchs; N Oelke; M Imhof; F Ochsendorf; H Schöfer; G Oromek; A Alaoui-Youssefi; I Emerit
Journal:  Mol Med       Date:  1998-05       Impact factor: 6.354

Review 7.  Cellular and molecular mechanisms involved in the establishment of HIV-1 latency.

Authors:  Daniel A Donahue; Mark A Wainberg
Journal:  Retrovirology       Date:  2013-02-01       Impact factor: 4.602

Review 8.  HIV-1 Trans Infection of CD4(+) T Cells by Professional Antigen Presenting Cells.

Authors:  Charles R Rinaldo
Journal:  Scientifica (Cairo)       Date:  2013-05-07

9.  Functional properties of the HIV-1 long terminal repeat containing single-nucleotide polymorphisms in Sp site III and CCAAT/enhancer binding protein site I.

Authors:  Sonia Shah; Aikaterini Alexaki; Vanessa Pirrone; Satinder Dahiya; Michael R Nonnemacher; Brian Wigdahl
Journal:  Virol J       Date:  2014-05-16       Impact factor: 4.099

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.